Indeed, TCGA SpliceSeq data showed a significant but relatively small decrease in Jmjd6-Ex5 in post mortem tissue of BRCA, COAD and LUSC, which links JMJD6-2 to cancer progression. This evidence concerns the gene JMJD6 and cancer.